Market-Moving News for April 23rd
Market-Moving News for April 23rd
ABEO: -55% | Abeona Therapeutics shares are trading lower after the company announced the FDA issued a Complete Response Letter in response to the company's Biologics License Application for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa.
ABEO：-55％ | Abeona Therapeutics的股價走低，此前該公司宣佈美國食品藥品管理局發佈了一封完整的回覆信，以回應該公司提出的用於治療隱性營養不良性大皰性表皮鬆解症患者的pz-cel的生物製劑許可申請。
CDNS: -10% | Cadence Design System shares are trading lower after the company issued Q2 adjusted EPS and sales guidance below estimates.
CDNS：-10％ | Cadence Design System的股價走低，此前該公司發佈的第二季度調整後每股收益和銷售指引低於預期。
IBRX: 41% | ImmunityBio Has Received FDA Approval For ANKTIVA, A First-In-Class IL-15 Receptor Agonist, For BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
IBRX：41% | ImmunityBio 已獲得 FDA 批准，這是一款同類首款 IL-15 受體激動劑，用於 BCG 無反應的非肌肉浸潤性膀胱癌
譯文內容由第三人軟體翻譯。